{"id":807,"date":"2019-10-15T13:11:46","date_gmt":"2019-10-15T00:11:46","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=807"},"modified":"2019-10-23T09:15:32","modified_gmt":"2019-10-22T20:15:32","slug":"cll-classification-systems","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=807","title":{"rendered":"CLL Classification Systems"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading heading_semantic=&#8221;h1&#8243; text_size=&#8221;h1&#8243;]<strong>CLL Classification Systems<\/strong>[\/vc_custom_heading][vc_column_text]This is the third in a series of slides from the recent CLL conference in Edinburgh that may be of interest to CLL patients.<\/p>\n<p>\u2018Rai\u2019 and \u2018Binet\u2019 are two classification systems for CLL disease severity, developed around the same time several decades ago. Rai is a US CLL expert, and Binet is a French expert. Both systems are still used, interchangeably. Some clinicians prefer one over the other. It\u2019s likely that another, more modern classification will be developed in the next few years.<\/p>\n<p><a href=\"https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1.png\"><img decoding=\"async\" class=\"alignnone wp-image-810 size-large\" src=\"https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1-1024x729.png\" alt=\"\" width=\"840\" height=\"598\" srcset=\"https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1-1024x729.png 1024w, https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1-300x213.png 300w, https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1-768x546.png 768w, https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1.png 2038w\" sizes=\"(max-width: 840px) 100vw, 840px\" \/><\/a><\/p>\n<p>Some explanations:<\/p>\n<p>The right-hand column is known disease duration since diagnosis in the individual patient being staged.<\/p>\n<p>RAI:<br \/>\nLymphocytosis = increased lymphocyte numbers in the blood.<br \/>\nLymphadenopathy = increase in lymph node size.<br \/>\nHb = haemoglobin, a measure of the red blood cells (Hb &lt; 11 is anaemia).<br \/>\nPlatelets &lt; 100,000 is a reduced platelet number<\/p>\n<p>BINET:<br \/>\nLymphoid areas = anatomical areas of lymph node enlargement eg enlargement of nodes under the armpits, in the groin etc.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2018Rai\u2019 and \u2018Binet\u2019 are two classification systems for CLL disease severity, developed around the same time several decades ago. Rai is a US CLL expert, and Binet is a French expert. Both systems are still used, interchangeably. Some clinicians prefer one over the other. It\u2019s likely that another, more modern classification will be developed in the next few years.<\/p>\n","protected":false},"author":1,"featured_media":810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12,19],"tags":[],"class_list":["post-807","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-news-media","category-cll-horizons-highlights","post_format-post-format-video"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/CLL-Clinical-Stages-1.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=807"}],"version-history":[{"count":3,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/807\/revisions"}],"predecessor-version":[{"id":812,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/807\/revisions\/812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/810"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}